Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of intravenous hydrocortisone in in-hospital acquired sepsis
TCTR20260416001Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydrocortisone in sepsis, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Planned start May 2026; status: not yet recruiting.
02
Drugs
hydrocortisone
03
Conditions
sepsis
Beyond the preview
Go deeper on TCTR20260416001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260416001.